NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE ANNOUNCEMENT.  Reference is made to the stock exchange announcements from Ensurge Micropower ASA (the "Company") dated 11 February 2025 ...

Core Points - Enovix Corporation announced that the alternate price condition for its warrants was satisfied on August 28, 2025, allowing for the exercise of warrants until 5:00 p.m. New York City time on August 29, 2025 [1][2] - Approximately 12.6 million warrants have been exercised, generating approximately $110.1 million in gross proceeds for the company [3] Warrant Details - Each warrant can be exercised for one share of common stock at an exercise price of $8.75 before the deadline [3] - The last day for trading warrants on Nasdaq is August 29, 2025, with trading ceasing at 4:00 p.m. New York City time [2] - After the deadline, unexercised warrants will be void, and holders will have no further rights [4] Exercise Process - The company has instituted a process for cash-exercising warrants using a Notice of Guaranteed Delivery, allowing holders to exercise their warrants even if their financial institution cannot complete the process in time [5] - Warrant holders must submit the Notice and payment before the exercise deadline [5] Company Overview - Enovix is a leader in advanced lithium-ion battery technology, focusing on silicon-anode batteries designed for various applications, including wearable electronics and electric vehicles [7] - The company is headquartered in Silicon Valley and has facilities in India, South Korea, and Malaysia [8]

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, SOUTH AFRICA, NEW ZEALAND, JAPAN OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL Reference is made to the stock exchange announcement made by Prosafe SE ("Prosafe" or the "Company") on 11 August 2025 regarding commencement of the exercise period (the "Exercise Period") f ...

Core Points - Neotech Metals Corp. has successfully closed a non-brokered private placement financing, raising a total of $1,472,338 [1][3] - The financing included the issuance of 660,810 non-flow through units at $0.17 per unit and 5,440,000 flow-through units at $0.25 per unit [2] - The net proceeds from the flow-through units will be allocated for qualified expenditures related to the company's mineral properties, while the proceeds from the non-flow through units will be used for general working capital [4] Financial Details - The non-flow through units consist of one common share and one share purchase warrant, with the warrant allowing the purchase of a common share at $0.35 for two years [2] - The flow-through units also include one common share and one share purchase warrant with the same terms as the non-flow through units [2] - The company received an additional $533,885 from warrant exercises in August [5] Company Overview - Neotech Metals Corp. is focused on mineral exploration and development, particularly in rare-earth elements and rare metals [7] - The company has a diversified portfolio of projects, including the Hecla-Kilmer project and others located in British Columbia, all of which are 100% owned [9]

Core Viewpoint - Aris Mining Corporation is reminding warrant holders that their TSX-listed warrants will expire on July 29, 2025, and any unexercised warrants will become void [1][2]. Warrant Exercise Summary - The warrants are currently "in-the-money" with an effective exercise price of C$5.50 per share, compared to a closing share price of C$9.46 on July 8, 2025 [2]. - Approximately 48.2% of the warrants have been exercised, generating C$77.0 million (approximately US$56 million) for the company [2][5]. - If all remaining outstanding warrants are exercised, Aris Mining would receive an additional C$83.0 million (approximately US$61 million) [2][5]. Financial Position - The CEO of Aris Mining stated that the expiry of the warrants simplifies the capital structure, eliminating legacy convertible instruments and resulting in a stronger balance sheet with over US$310 million in cash as of June 30 [3]. Company Overview - Aris Mining was founded in September 2022, focusing on becoming a leading gold mining company in Latin America, combining current production with growth through expansions and exploration [6]. - The company operates two underground gold mines in Colombia, targeting an annual production rate of over 500,000 ounces of gold following recent expansions [7][9]. Future Plans - Aris Mining is pursuing acquisitions and growth opportunities to enhance value through scale and diversification [10].

Core Viewpoint - SenesTech, Inc. has entered into definitive agreements for the immediate exercise of outstanding warrants to purchase 1,458,872 shares of common stock at an exercise price of $2.90 per share, with the transaction expected to close around July 1, 2025 [1] Group 1: Warrant Exercise and Financial Details - The company will issue new unregistered short-term warrants to purchase an additional 1,458,872 shares at an exercise price of $4.15 per share, with a purchase price of $0.125 per warrant [3] - The gross proceeds from the exercise of existing warrants are expected to be approximately $4.4 million, while potential gross proceeds from the new short-term warrants could reach approximately $6.0 million if fully exercised [4] - The net proceeds from the transaction are intended for working capital and general corporate purposes [4] Group 2: Regulatory and Compliance Information - The resale of shares from the existing warrants has been registered under an effective registration statement on Form S-3 [5] - The new short-term warrants have not been registered under the Securities Act of 1933, and may not be offered or sold in the U.S. without an effective registration statement or applicable exemption [6] Group 3: Company Overview - SenesTech is focused on humane management of animal pest populations through fertility control, with products like ContraPest® and Evolve™ designed for effective pest management [8]